Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT05817825
- Status
- Recruiting
Conditions
- Opioid Use Disorder
- Serious Bacterial Infections
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Smart IOP Intervention — BEHAVIORALSmart IOP is a remotely delivered IOP program in operation since 2016, allowing patients to complete addiction treatment entirely online. The original program, consisting of 72 video modules across 8 different topics, will be adapted and tailored to hospitalized patients with serious infections from injection drug use. Participants will watch video content asynchronously, and will be required to correctly answer knowledge questions to proceed to the next module. The whole treatment program will require approximately 4 weeks to complete. Participants are also asked to answer questions about how to apply the knowledge to their own personal circumstances. The answers to these are reviewed by the peer recovery coach during weekly encounters. Videos can be viewed at a time that is most convenient to the participants. T
- Peer Recovery Coach — BEHAVIORALPeer recovery coach, an individual in sustained recovery (\>5 years) and certified to be a coach, will meet weekly with the participant to review progress, answer questions about the videos, review answers to questions, and encourage continuation of treatment after discharge. These meetings will occur in-person or remotely.
Study Details
This study aims to test a remotely delivered IOP program ("SmartIOP") for OUD patients who are hospitalized for serious injection-related infections. This will be a pilot trial to assess the feasibility of the IOP program and examine OUD-related outcomes following discharge from the hospital.
Key Dates
- Start date
- Nov 17, 2023
- Status verified
- Jul 2024
- Primary completion
- Nov 30, 2024
- Completion
- Dec 31, 2024
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment GroupThe intervention to be developed and tested has two components: 1) the remotely delivered IOP ("Smart IOP"), and 2) a peer recovery coach to provide support and accountability to the participant.
Primary Outcome Measure
Feasibility of the intervention program [ Time Frame: Immediately Post Intervention ]
Central Contacts
- Joji Suzuki, MD617-732-5752
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Joji Suzuki, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By research site
Related Studies
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Supporting Treatment Access and Recovery in CODRecruiting · University of Massachusetts, Worcester · Holyoke, Massachusetts
- Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized TrialNot Yet Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ StudyRecruiting · Boston Medical Center · Boston, Massachusetts